Researchers have identified a new way to target a previously undruggable form of lung cancer, which has shown promise in ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

ARTAN Bio, a longevity biotechnology company based in St. Petersburg, Florida, today announced the close of a $1 million seed round led by company co-founder Michael Torres, Ph.D., following his role ...

Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...

The Cambridge programme opened with keynote contributions from George Freeman MP, Prof Deborah Prentice, vice-chancellor of ...

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

Artan Biotechnologies LLC has closed a $1 million seed round to support progression of the company’s proprietary mutation-specific codon suppression platform toward first-in-human development.

A Cornell-led study is challenging a decades-old explanation for how chromosomes exchange genetic material within the ...

The Huntington's disease market is projected to experience steady growth, supported by progress in precision medicine, rising investments in research and development, and a deeper understanding ...